Can CLABSI Rates Be Reduced in Pediatric Oncology Patients?

Implementation of a central-line maintenance care bundle resulted in reductions of 20% to 64%, but the decreases were not statistically significant.

Pediatric quality-improvement studies have demonstrated reductions in central line–associated bloodstream infections (CLABSIs), but until now, no such investigations have involved an entire inpatient oncology cohort. In a recent single-center, prospective, interventional study conducted in an 18-bed pediatric oncology unit, researchers included both stem cell transplant recipients and children undergoing treatment of malignancies. In addition, the researchers focused only on optimizing catheter-maintenance procedures because of previous evidence suggesting that improvement in these procedures is significantly associated with decreased pediatric CLABSI rates.

Baseline CLABSI rates were established from January through October 2009. In Novembe…

Reviewing Author

Robert S. Baltimore, MD

Disclosures

Editorial BoardsInfectious Diseases in Children

Leadership Positions in Professional SocietiesMember Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease

Robert S. Baltimore, MD

Disclosures

Editorial BoardsInfectious Diseases in Children

Leadership Positions in Professional SocietiesMember Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease

Can CLABSI Rates Be Reduced in Pediatric Oncology Patients?

Topics

Reviewing Author